Dermatological manifestations of chronic liver disease
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20181824Keywords:
Skin manifestations, Chronic liver diseaseAbstract
Background: The present study was conducted to assess the spectrum of cutaneous changes in chronic liver disease and to assess any correlation between the skin findings and the type of the liver disease.
Methods: A total of 100 patients above 18 years of age suffering from chronic liver disease with cutaneous manifestations and attending the Gastroenterology and Dermatology and Venereology department of Gauhati Medical College and Hospital, Guwahati, India during the period from June 2016 to May 2017 were included in the study.
Results: Out of 100 cases, there were 84 males (84%) and 16 females (16%) with the male to female ratio of 5.25:1. Alcoholic liver disease comprised 62% of the patients in the study, other causes being cryptogenic liver disease (14%), chronic hepatitis infection (12%), Wilson’s disease (2%), autoimmune hepatitis (2%), hepatocellular carcinoma (2%), methotrexate induced liver disease (1%) and non-alcoholic steatohepatitis (1%). Most common skin finding was xerosis (62%). Other key findings included nail changes (60%), pigmentary changes (55%), hair changes (50%), jaundice (40%), cutaneous infections (31%), pruritus (27%).
Conclusions: Patients with chronic liver disease can have a wide spectrum of cutaneous manifestations the most important being xerosis, nail changes, pigmentary changes, hair changes, jaundice, infections, pruritus and spider angioma. These changes can give a clue to the presence of the underlying liver disease and its severity. Hence, identifying these signs earlier can lead to prompt diagnosis and effective management of the underlying condition, thereby preventing its complications.
References
Graham-Brown RAC. The Hepatobiliary system and the Skin. In: Fitzpatrick’s Dermatology in General Medicine 5th edn., Freedberg IAE, Austen KF, Goldsmith LA, Katz SI, Wolff K, Fitzpatric T, eds. New York: McGraw- Hill; 1998: 1918.
Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 1992;327:1490-5.
Hazin R, Tarek I Abu-Rajab Tamimi, Jamil Y Abuzetun, Nizar N Zein; Recognizing and Treating Cutaneous signs of Liver Disease. Cleveland Clin J Med. 2009;76(10):599-606.
Colinogilvie D, Cristopher C, Evans CC, eds. Chamberlain’s Symptoms and Signs in Clinical Medicine, 12th edn. Buttterworth: Heinsmann; 1997.
Lawarance S, Friedman LS, eds. Current Medical Diagnosis and Treatment, 41st edn. New York: McGraw-Hill; 2002.
Raymond T, Chung RT, Daniel K, Podolsky DK. Cirrhosis and its complications. In: Fauci AS, Braunwald E, Iseelbacker KJ, eds. Harrison’s Principles of Internal Medicine, 18th edn. New York: McGraw-Hill; 2012: 2592-2602.
Pawlotsky JM, Dhumeaux D, Bagot M. Hepatitis C virus in dermatology. Arch Dermatol. 1995;131:1185-93.
Monk B. Lichen planus and the liver. J Am Acad Dermatol. 1985;12:122-3.
Gandelman G, Aronow WS, Weiss MB. Resolving hyperlipidemia after liver transplantation in a patient with primary sclerosing cholangitis. Am J Ther. 2006;13:171–4.
Bahnsen M, Gluud C, Johnsen SG, Bennett P, Svenstrup S, Micic S, et al. Pituitary–testicular function in patients with alcoholic cirrhosis of the liver. Eur J Clin Invest. 1981;11:473–9.
Kumar N, Aggarwal SR, Anand BS. Comparison of truncal hair distribution in alcoholic liver disease and alcohol-related chronic pancreatitis. J Gastroenterol Hepatol. 2001;16:855–6.
Holzberg M, Walker HK. Terry’s nails: revised definition and new correlations. Lancet. 1984;1:896–9.
Cox NH, Coulson IH. Systemic diseases and the skin. In: Rook’s Textbook of Dermatology. 8th ed. Burns T, Breathnach S, Cox N, Griffith C, eds. Wiley Blackwell: Singapore. 2010:62.1–62.113.
Niaz Shaikh A, Baloch AA, Irfan M, Vaswani AS, Moghal FA, Ali SE. Clinical signs of chronic liver disease: Is there any difference in patients with hepatitis B and C. Medical channel. 2010;16(2):233-6.
Jai G, Dubey AK, Alex A, Jain RK. A clinical study of cutaneous manifestations in liver diseases. J Evol Med Dental Sci. 2013;2(39):7523-9.
Sayal SK, Gupta CM, Das AL, Chattwal PK. A comparative study of liver function tests in patients of chronic liver disorders with and without cutaneous manifestations. Indian J Dermatol Venereol Leprol. 1997;63:159.
Yoon YH, Yi HY. Surveillance report #75: liver cirrhosis mortality in the United States, 1970–2003. National Institute on Alcohol Abuse and Alcoholism: Bethesda, MD, 2006.
Khan MM, Noor SM, Rehman S, Syed A, Khan IM, Hameed K. Cutaneous Manifestations of chronic liver disease. J Pak Assoc Derma. 2005;15(3):233-7.
Salem A, Gamil H, Hamed M, Galal S. Nail changes in patients with liver disease. J Eur Acad Dermatol Venereol. 2010;24(6):649-54.
Olczak-Kowalczyk D, Kowalczyk W, Krasuska-Sławińska E, Dądalski M, KostewiczK, Pawłowska J. Oral health and liver function in children and adolescents with cirrhosis of the liver. Prz Gastroenterol. 2014;9(1):24-31.
Rongey C, Lim NH, Runyon BA. Cellulitis in Patients with Cirrhosis and Edema: An Under-Recognized Complication Currently More Common than Spontaneous Bacterial Peritonitis. Open Gastroenterol J. 2008;2:24-7.
Rao GS. Cutaneous changes in chronic alcoholics. Indian J Dermatol Venereol Leprol. 2004;70:79-81.
